Quest Diagnostics Incorporated (DGX)
NYSE: DGX · IEX Real-Time Price · USD
136.64
-0.45 (-0.33%)
At close: Jul 2, 2024, 4:00 PM
137.62
+0.98 (0.72%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $9.29B in the twelve months ending March 31, 2024, down -3.29% year-over-year. Revenue in the quarter ending March 31, 2024 was $2.37B with 1.50% year-over-year growth. In the year 2023, Quest Diagnostics had annual revenue of $9.25B, a decrease of -6.38%.
Revenue (ttm)
$9.29B
Revenue Growth
-3.29%
P/S Ratio
1.63
Revenue / Employee
$193,479
Employees
48,000
Market Cap
15.18B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
Dec 31, 2019 | 7.73B | 195.00M | 2.59% |
Dec 31, 2018 | 7.53B | 129.00M | 1.74% |
Dec 31, 2017 | 7.40B | 188.00M | 2.61% |
Dec 31, 2016 | 7.21B | -279.00M | -3.72% |
Dec 31, 2015 | 7.49B | 58.00M | 0.78% |
Dec 31, 2014 | 7.44B | 289.00M | 4.04% |
Dec 31, 2013 | 7.15B | -237.00M | -3.21% |
Dec 31, 2012 | 7.38B | -9.00M | -0.12% |
Dec 31, 2011 | 7.39B | 131.88M | 1.82% |
Dec 31, 2010 | 7.26B | -195.12M | -2.62% |
Dec 31, 2009 | 7.46B | 205.80M | 2.84% |
Dec 31, 2008 | 7.25B | 544.54M | 8.12% |
Dec 31, 2007 | 6.70B | 436.25M | 6.96% |
Dec 31, 2006 | 6.27B | 811.93M | 14.88% |
Dec 31, 2005 | 5.46B | 389.74M | 7.69% |
Dec 31, 2004 | 5.07B | 329.03M | 6.94% |
Dec 31, 2003 | 4.74B | 629.91M | 15.33% |
Dec 31, 2002 | 4.11B | 480.28M | 13.24% |
Dec 31, 2001 | 3.63B | 206.61M | 6.04% |
Dec 31, 2000 | 3.42B | 1.22B | 55.14% |
Dec 31, 1999 | 2.21B | 746.64M | 51.19% |
Dec 31, 1998 | 1.46B | -70.09M | -4.58% |
Dec 31, 1997 | 1.53B | -87.60M | -5.42% |
Dec 31, 1996 | 1.62B | -13.09M | -0.80% |
Dec 31, 1995 | 1.63B | -4.31M | -0.26% |
Dec 31, 1994 | 1.63B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Baxter International | 14.89B |
Illumina | 4.49B |
Incyte | 3.77B |
BeiGene | 2.76B |
Genmab | 2.57B |
United Therapeutics | 2.50B |
BioMarin Pharmaceutical | 2.47B |
Neurocrine Biosciences | 1.98B |
DGX News
- 5 days ago - Quest Diagnostics Releases 2023 Corporate Responsibility Report - PRNewsWire
- 6 days ago - Quest Diagnostics to Acquire Select Lab Assets from Allina Health - PRNewsWire
- 13 days ago - Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024 - PRNewsWire
- 21 days ago - Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics' Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis - PRNewsWire
- 4 weeks ago - Blood-based MRD Test for Cancer Recurrence Can Generate Cost Savings in Colorectal Cancer Treatment, Finds Study in JAMA Health Forum - PRNewsWire
- 6 weeks ago - Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors - PRNewsWire
- 6 weeks ago - Quest Diagnostics Declares Quarterly Cash Dividend - PRNewsWire
- 6 weeks ago - Workforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug Tests - PRNewsWire